dose finding study of irinotecan for UGT1A1 homozygnous group
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: Administraion of irinotecan is twice for 4 weeks . Adjusted dosage is determined from 100or125 mg/sqm in the heterozygous group . Primary outcome(s): adverse events Study Design: Single arm Non-randomized
创建时间：
2009-10-15
相关数据集
暂无相关数据集
